VALIANTLABPharmaceuticals
Valiant Laboratories Ltd — Balance Sheet
₹51.62
-5.74%
Valiant Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Stockholders Equity | 234.31 Cr | 236.86 Cr | 100.49 Cr | 71.46 Cr | — |
| Other Equity Interest | 190.86 Cr | 193.41 Cr | — | — | — |
| Capital Stock | 43.45 Cr | 43.45 Cr | 32.56 Cr | 16.28 Cr | — |
| Common Stock | 43.45 Cr | 43.45 Cr | 32.56 Cr | 16.28 Cr | — |
| Total Liabilities Net Minority Interest | 166.55 Cr | 105.83 Cr | 112.47 Cr | 110.35 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 106.93 Cr | 76.75 Cr | 61.75 Cr | 60.92 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 0.13 Cr | 0.08 Cr | 0.08 Cr | 0.00 | — |
| Non Current Deferred Taxes Liabilities | 1.24 Cr | 0.62 Cr | 0.67 Cr | 0.30 Cr | — |
| Long Term Debt And Capital Lease Obligation | 104.60 Cr | 75.09 Cr | 60.04 Cr | 59.67 Cr | — |
| Long Term Capital Lease Obligation | 0.25 Cr | 0.43 Cr | 0.64 Cr | 0.27 Cr | — |
| Long Term Debt | 104.35 Cr | 74.66 Cr | 59.40 Cr | 59.40 Cr | — |
| Current Liabilities | 59.62 Cr | 29.08 Cr | 50.73 Cr | 49.43 Cr | — |
| Other Current Liabilities | 0.26 Cr | 0.20 Cr | 0.99 Cr | — | -0.05 Cr |
| Current Debt And Capital Lease Obligation | 17.09 Cr | 1.62 Cr | 0.17 Cr | 1.46 Cr | — |
| Current Capital Lease Obligation | 0.23 Cr | 0.23 Cr | 0.17 Cr | 0.18 Cr | — |
| Current Debt | 16.86 Cr | 1.39 Cr | 0.00 | 1.28 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 0.20 Cr | 0.12 Cr | 0.12 Cr | 0.16 Cr | — |
| Payables | 40.72 Cr | 25.93 Cr | 48.01 Cr | 47.20 Cr | — |
| Total Tax Payable | 0.00 | — | 0.00 | — | — |
| Accounts Payable | 40.72 Cr | 25.93 Cr | 47.30 Cr | 46.44 Cr | — |
| Total Assets | 400.86 Cr | 342.69 Cr | 212.97 Cr | 181.81 Cr | — |
| Total Non Current Assets | 208.24 Cr | 117.14 Cr | 62.39 Cr | 25.01 Cr | — |
| Other Non Current Assets | 0.45 Cr | 21.00 Cr | 12.35 Cr | 0.73 Cr | — |
| Investmentin Financial Assets | 3.57 Cr | 3.44 Cr | 0.00 | — | — |
| Available For Sale Securities | 3.57 Cr | 3.44 Cr | — | — | — |
| Long Term Equity Investment | 0.00 | 0.00 | — | 0.00 | 0.00 |
| Investmentsin Subsidiariesat Cost | 0.00 | 0.00 | — | 0.00 | 0.00 |
| Goodwill And Other Intangible Assets | 0.11 Cr | — | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.11 Cr | — | — | — | — |
| Goodwill | 0.00 | — | 0.00 | 0.00 | 0.00 |
| Net PPE | 204.11 Cr | 92.70 Cr | 48.80 Cr | 23.67 Cr | — |
| Gross PPE | 204.11 Cr | 92.70 Cr | 66.99 Cr | 31.20 Cr | — |
| Construction In Progress | 155.78 Cr | 42.65 Cr | 0.68 Cr | 1.45 Cr | — |
| Other Properties | 48.33 Cr | 50.05 Cr | 0.35 Cr | 0.18 Cr | — |
| Current Assets | 192.62 Cr | 225.54 Cr | 150.58 Cr | 156.80 Cr | — |
| Other Current Assets | 38.26 Cr | 21.87 Cr | 20000.00 | 10000.00 | — |
| Inventory | 3.99 Cr | 10.02 Cr | 13.04 Cr | 15.80 Cr | — |
| Other Receivables | 0.06 Cr | 0.03 Cr | 0.79 Cr | 0.73 Cr | — |
| Taxes Receivable | 2.19 Cr | 4.08 Cr | — | — | — |
| Accounts Receivable | 72.12 Cr | 45.73 Cr | 88.57 Cr | 110.77 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 75.99 Cr | 143.82 Cr | 35.36 Cr | 20.53 Cr | — |
| Other Short Term Investments | 71.07 Cr | 132.11 Cr | 34.10 Cr | 20.40 Cr | — |
| Cash And Cash Equivalents | 4.92 Cr | 11.72 Cr | 1.26 Cr | 0.13 Cr | — |
| Ordinary Shares Number | 4.68 Cr | 4.68 Cr | 4.68 Cr | 4.68 Cr | — |
| Share Issued | 4.68 Cr | 4.68 Cr | 4.68 Cr | 4.68 Cr | — |
| Net Debt | 116.29 Cr | 64.33 Cr | 58.14 Cr | 60.55 Cr | — |
| Total Debt | 121.69 Cr | 76.71 Cr | 60.22 Cr | 61.13 Cr | — |
| Tangible Book Value | 234.20 Cr | 236.86 Cr | 100.49 Cr | 71.46 Cr | — |
| Invested Capital | 355.51 Cr | 312.91 Cr | 159.89 Cr | 132.14 Cr | — |
| Working Capital | 133.00 Cr | 196.47 Cr | 99.85 Cr | 107.37 Cr | — |
| Net Tangible Assets | 234.20 Cr | 236.86 Cr | 100.49 Cr | 71.46 Cr | — |
| Capital Lease Obligations | 0.48 Cr | 0.66 Cr | 0.82 Cr | 0.45 Cr | — |
| Common Stock Equity | 234.31 Cr | 236.86 Cr | 100.49 Cr | 71.46 Cr | — |
| Total Capitalization | 338.66 Cr | 311.52 Cr | 159.89 Cr | 130.86 Cr | — |
| Total Equity Gross Minority Interest | 234.31 Cr | 236.86 Cr | 100.49 Cr | 71.46 Cr | — |
| Other Non Current Liabilities | — | 2000.00 | 0.96 Cr | 10000.00 | 10000.00 |
| Minority Interest | — | — | 0.00 | — | — |
| Retained Earnings | — | — | 51.59 Cr | 22.56 Cr | 78.08 Cr |
| Additional Paid In Capital | — | — | 16.34 Cr | 32.62 Cr | 0.00 |
| Other Payable | — | — | 0.71 Cr | 0.76 Cr | 0.29 Cr |
| Non Current Prepaid Assets | — | — | 1.24 Cr | 0.61 Cr | 0.60 Cr |
| Accumulated Depreciation | — | — | -18.19 Cr | -7.53 Cr | -5.33 Cr |
| Machinery Furniture Equipment | — | — | 29.77 Cr | 14.57 Cr | 12.57 Cr |
| Buildings And Improvements | — | — | 13.53 Cr | 15.01 Cr | 12.34 Cr |
| Land And Improvements | — | — | 22.65 Cr | — | — |
| Properties | — | — | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | — | 12.81 Cr | 8.96 Cr | 10.30 Cr |
| Other Inventories | — | — | 0.02 Cr | 0.06 Cr | 0.12 Cr |
| Finished Goods | — | — | 3.03 Cr | 2.17 Cr | 0.88 Cr |
| Work In Process | — | — | 2.06 Cr | 2.68 Cr | 1.99 Cr |
| Raw Materials | — | — | 7.93 Cr | 10.90 Cr | 3.08 Cr |
| Allowance For Doubtful Accounts Receivable | — | — | -0.24 Cr | 0.00 | 0.00 |
| Gross Accounts Receivable | — | — | 88.81 Cr | 110.77 Cr | 42.51 Cr |
| Cash Financial | — | — | 1.26 Cr | 0.13 Cr | 3.94 Cr |
| Current Deferred Taxes Liabilities | — | — | — | 0.00 | 2.22 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Valiant Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.